These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10821643)

  • 1. Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease.
    Tohgi H; Abe T; Yamazaki K; Murata T; Ishizaki E; Isobe C
    Neurosci Lett; 1999 Jul; 269(1):52-4. PubMed ID: 10821643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment.
    Ahmed N; Ahmed U; Thornalley PJ; Hager K; Fleischer G; Münch G
    J Neurochem; 2005 Jan; 92(2):255-63. PubMed ID: 15663474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease.
    Abe T; Tohgi H; Murata T; Isobe C; Sato C
    Neurosci Lett; 2001 Oct; 312(3):177-9. PubMed ID: 11602339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease.
    Korolainen MA; Pirttilä T
    Acta Neurol Scand; 2009 Jan; 119(1):32-8. PubMed ID: 18547271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The correlation of asymmetrical dimethylarginine level and oxidative stress to the onset of Alzheimer's disease].
    Chen M; Jiang P; Lü J; Xiang ZH; Jiao BH
    Yao Xue Xue Bao; 2010 Aug; 45(8):1001-5. PubMed ID: 21351586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease.
    Ryberg H; Söderling AS; Davidsson P; Blennow K; Caidahl K; Persson LI
    Neurochem Int; 2004 Jul; 45(1):57-62. PubMed ID: 15082222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis.
    Tohgi H; Abe T; Yamazaki K; Murata T; Ishizaki E; Isobe C
    Ann Neurol; 1999 Jul; 46(1):129-31. PubMed ID: 10401792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a novel double-sandwich enzyme-linked immunosorbent assay method for assaying chondroitin sulfate proteoglycans that bear 3-nitrotyrosine core protein modifications, a previously unrecognized proteoglycan modification in hydrocephalus.
    Krueger RC
    Anal Biochem; 2004 Feb; 325(1):52-61. PubMed ID: 14715284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation.
    Lüth HJ; Münch G; Arendt T
    Brain Res; 2002 Oct; 953(1-2):135-43. PubMed ID: 12384247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of neuronal oxidative damage in Alzheimer's disease.
    Good PF; Werner P; Hsu A; Olanow CW; Perl DP
    Am J Pathol; 1996 Jul; 149(1):21-8. PubMed ID: 8686745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remarkable increase in 3-nitrotyrosine in the cerebrospinal fluid in patients with lacunar stroke.
    Isobe C; Abe T; Terayama Y
    Brain Res; 2009 Dec; 1305():132-6. PubMed ID: 19815006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
    Butterfield DA; Reed TT; Perluigi M; De Marco C; Coccia R; Keller JN; Markesbery WR; Sultana R
    Brain Res; 2007 May; 1148():243-8. PubMed ID: 17395167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases.
    Aoyama K; Matsubara K; Fujikawa Y; Nagahiro Y; Shimizu K; Umegae N; Hayase N; Shiono H; Kobayashi S
    Ann Neurol; 2000 Apr; 47(4):524-7. PubMed ID: 10762167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid levels of nitric oxide and nitrotyrosine in neonates with mild hypoxic-ischemic encephalopathy.
    Gücüyener K; Ergenekon E; Demiryürek T; Erbaş D; Oztürk G; Koç E; Atalay Y
    J Child Neurol; 2002 Nov; 17(11):815-8. PubMed ID: 12585720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease.
    Mitsui S; Okui A; Uemura H; Mizuno T; Yamada T; Yamamura Y; Yamaguchi N
    Ann N Y Acad Sci; 2002 Nov; 977():216-23. PubMed ID: 12480753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid C3a increases with age, but does not increase further in Alzheimer's disease.
    Loeffler DA; Brickman CM; Juneau PL; Perry MF; Pomara N; Lewitt PA
    Neurobiol Aging; 1997; 18(5):555-7. PubMed ID: 9390784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease.
    Fernández-Vizarra P; Fernández AP; Castro-Blanco S; Encinas JM; Serrano J; Bentura ML; Muñoz P; Martínez-Murillo R; Rodrigo J
    Neurobiol Dis; 2004 Mar; 15(2):287-305. PubMed ID: 15006699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation.
    Hensley K; Maidt ML; Yu Z; Sang H; Markesbery WR; Floyd RA
    J Neurosci; 1998 Oct; 18(20):8126-32. PubMed ID: 9763459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
    Zimetti F; Caffarra P; Ronda N; Favari E; Adorni MP; Zanotti I; Bernini F; Barocco F; Spallazzi M; Galimberti D; Ricci C; Ruscica M; Corsini A; Ferri N
    J Alzheimers Dis; 2017; 55(1):315-320. PubMed ID: 27662294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.
    Kanai M; Matsubara E; Isoe K; Urakami K; Nakashima K; Arai H; Sasaki H; Abe K; Iwatsubo T; Kosaka T; Watanabe M; Tomidokoro Y; Shizuka M; Mizushima K; Nakamura T; Igeta Y; Ikeda Y; Amari M; Kawarabayashi T; Ishiguro K; Harigaya Y; Wakabayashi K; Okamoto K; Hirai S; Shoji M
    Ann Neurol; 1998 Jul; 44(1):17-26. PubMed ID: 9667589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.